ArticleCancer management and research2020

ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway.

Guangliang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.